| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2008PLoSO...3.1882F |
| P356 | DOI | 10.1371/JOURNAL.PONE.0001882 |
| P932 | PMC publication ID | 2266992 |
| P698 | PubMed publication ID | 18365023 |
| P5875 | ResearchGate publication ID | 5487476 |
| P50 | author | Elisabeth Paietta | Q69071275 |
| Peter H. Wiernik | Q100309276 | ||
| Reid F Thompson | Q41312233 | ||
| John Greally | Q42667137 | ||
| P2093 | author name string | Roland D Green | |
| Ari Melnick | |||
| Kenny Ye | |||
| Mark Reimers | |||
| Maria E Figueroa | |||
| Yushan Li | |||
| Jakob Fridriksson | |||
| Rebecca R Selzer | |||
| P2860 | cites work | Aberrant methylation and impaired expression of the p15(INK4b) cell cycle regulatory gene in chronic myelomonocytic leukemia (CMML). | Q54773230 |
| The fundamental role of epigenetic events in cancer | Q56421597 | ||
| Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia | Q57240085 | ||
| Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia | Q78125085 | ||
| Large-scale CpG methylation analysis identifies novel candidate genes and reveals methylation hotspots in acute lymphoblastic leukemia | Q38303652 | ||
| Interactive exploration of microarray gene expression patterns in a reduced dimensional space | Q39860879 | ||
| hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site | Q40185373 | ||
| DNA methylation immediately adjacent to active histone marking does not silence transcription. | Q40187418 | ||
| Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia | Q40267029 | ||
| Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatic chromatin state | Q40296469 | ||
| Triple analysis of the cancer epigenome: an integrated microarray system for assessing gene expression, DNA methylation, and histone acetylation | Q40650614 | ||
| Mapping global histone acetylation patterns to gene expression | Q44928696 | ||
| CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas | Q45009128 | ||
| Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas | Q46610612 | ||
| Prognostically useful gene-expression profiles in acute myeloid leukemia. | Q51999490 | ||
| DNA methylation patterns and epigenetic memory | Q22065780 | ||
| Translating the Histone Code | Q22065840 | ||
| Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? | Q22251049 | ||
| Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry | Q24536837 | ||
| Cluster analysis and display of genome-wide expression patterns | Q24644463 | ||
| The human genome browser at UCSC | Q24672361 | ||
| Comparative isoschizomer profiling of cytosine methylation: the HELP assay | Q24685607 | ||
| Quality assessment of microarrays: visualization of spatial artifacts and quantitation of regional biases | Q24815050 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma | Q27824784 | ||
| Worms gang up on bacteria | Q27860588 | ||
| Molecular classification of cancer: class discovery and class prediction by gene expression monitoring | Q27861072 | ||
| Genomic maps and comparative analysis of histone modifications in human and mouse | Q29614418 | ||
| Methylation of histone H3 Lys 4 in coding regions of active genes | Q29614680 | ||
| Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma | Q29615026 | ||
| Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer | Q29615066 | ||
| Gene silencing in cancer in association with promoter hypermethylation | Q29617274 | ||
| Quantitative assessment of gene targeting in vitro and in vivo by the pancreatic transcription factor, Pdx1. Importance of chromatin structure in directing promoter binding | Q30308636 | ||
| Correspondence analysis applied to microarray data | Q30659762 | ||
| MADE4: an R package for multivariate analysis of gene expression data | Q30986013 | ||
| Diverse histone modifications on histone 3 lysine 9 and their relation to DNA methylation in specifying gene silencing | Q33285707 | ||
| Analysis of chromosome breakpoints in neuroblastoma at sub-kilobase resolution using fine-tiling oligonucleotide array CGH. | Q34439696 | ||
| DNA methylation changes in leukaemia | Q34792998 | ||
| High-throughput screening of chromatin immunoprecipitates using CpG-island microarrays | Q35671786 | ||
| MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia | Q38294261 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e1882 | |
| P577 | publication date | 2008-03-26 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | An integrative genomic and epigenomic approach for the study of transcriptional regulation | |
| P478 | volume | 3 |
| Q33502760 | A comprehensive microarray-based DNA methylation study of 367 hematological neoplasms |
| Q24296658 | ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression |
| Q34568861 | Aberrant DNA hypermethylation signature in acute myeloid leukemia directed by EVI1. |
| Q35107545 | Aberrant epigenetic and genetic marks are seen in myelodysplastic leukocytes and reveal Dock4 as a candidate pathogenic gene on chromosome 7q |
| Q24655104 | Allele-specific gene expression patterns in primary leukemic cells reveal regulation of gene expression by CpG site methylation |
| Q34513460 | Bromodomain coactivators in cancer, obesity, type 2 diabetes, and inflammation |
| Q36249453 | CD25 expression status improves prognostic risk classification in AML independent of established biomarkers: ECOG phase 3 trial, E1900. |
| Q37423780 | Chromatin maps, histone modifications and leukemia. |
| Q51542367 | Chromatin modifications induced by the AML1-ETO fusion protein reversibly silence its genomic targets through AML1 and Sp1 binding motifs. |
| Q37308540 | Contributions of extracellular matrix signaling and tissue architecture to nuclear mechanisms and spatial organization of gene expression control |
| Q37796732 | DNA methylation alterations in multiple myeloma as a model for epigenetic changes in cancer |
| Q37740461 | DNA methylation profiling using HpaII tiny fragment enrichment by ligation-mediated PCR (HELP) |
| Q34360406 | DNA methylation signatures define molecular subtypes of diffuse large B-cell lymphoma |
| Q34433577 | DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia. |
| Q34183409 | Development of a multiplex methylation specific PCR suitable for (early) detection of non-small cell lung cancer |
| Q37215179 | Development of acute megakaryoblastic leukemia in Down syndrome is associated with sequential epigenetic changes |
| Q36593790 | Differential gene body methylation and reduced expression of cell adhesion and neurotransmitter receptor genes in adverse maternal environment |
| Q33409795 | Differentiation therapy of leukemia: 3 decades of development |
| Q34643306 | Epigenetic differences in cytogenetically normal versus abnormal acute myeloid leukemia |
| Q50904123 | Epigenetically Aberrant Stroma in MDS Propagates Disease via Wnt/β-Catenin Activation |
| Q57175475 | Genetics and epigenetics of pediatric leukemia in the era of precision medicine |
| Q34156717 | Genome-wide epigenetic analysis delineates a biologically distinct immature acute leukemia with myeloid/T-lymphoid features. |
| Q44097865 | Genome-wide profiling of methylation identifies novel targets with aberrant hypermethylation and reduced expression in low-risk myelodysplastic syndromes. |
| Q37374239 | Genomic tools for dissecting oncogenic transcriptional networks in human leukemia |
| Q37602230 | HSC commitment-associated epigenetic signature is prognostic in acute myeloid leukemia |
| Q36724881 | High resolution methylome analysis reveals widespread functional hypomethylation during adult human erythropoiesis |
| Q37259044 | High-resolution genome-wide cytosine methylation profiling with simultaneous copy number analysis and optimization for limited cell numbers. |
| Q37085575 | Hypomethylation of noncoding DNA regions and overexpression of the long noncoding RNA, AFAP1-AS1, in Barrett's esophagus and esophageal adenocarcinoma |
| Q33359567 | In vitro analysis of integrated global high-resolution DNA methylation profiling with genomic imbalance and gene expression in osteosarcoma |
| Q41473465 | Integrated genetic and epigenetic analysis of childhood acute lymphoblastic leukemia |
| Q35891590 | Integrative and regularized principal component analysis of multiple sources of data |
| Q42394189 | Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemia |
| Q35582141 | Kidney cancer is characterized by aberrant methylation of tissue-specific enhancers that are prognostic for overall survival |
| Q83226924 | Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts |
| Q37396081 | MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation |
| Q33594374 | Making informed choices about microarray data analysis |
| Q33880512 | Methylome profiling reveals distinct alterations in phenotypic and mutational subgroups of myeloproliferative neoplasms |
| Q34234115 | Mutated in colorectal cancer (MCC) is a novel oncogene in B lymphocytes |
| Q83186138 | NCI first International Workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on the biological considerations of hematological relapse following allogeneic |
| Q37637014 | Next generation sequencing: advances in characterizing the methylome |
| Q49478791 | Nonlinear Joint Latent Variable Models and Integrative Tumor Subtype Discovery |
| Q39138075 | Notch Pathway Is Activated via Genetic and Epigenetic Alterations and Is a Therapeutic Target in Clear Cell Renal Cancer |
| Q37901485 | Targeting epigenetics through histone deacetylase inhibitors in acute lymphoblastic leukemia |
| Q42626682 | The Einstein Center for Epigenomics: studying the role of epigenomic dysregulation in human disease |
| Q33869648 | Widespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesis |
| Q90054171 | pathCHEMO, a generalizable computational framework uncovers molecular pathways of chemoresistance in lung adenocarcinoma |
Search more.